Business
Press Release Sep 20 2023
Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated September 20, 2023, titled "Press Release regarding grant of final approval by the United States Food and Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA) Norepinephrine Bitartrate Injection USP, to our Subsidiary Caplin Steriles Limited. ".
About this update from Caplin Point Laboratories Limited
[{"type":"text","content":" Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated September 20, 2023, titled \"Press Release regarding grant of final approval by the United States Food and Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA) Norepinephrine Bitartrate Injection USP, to our Subsidiary Caplin Steriles Limited. \". View Attachment","length":527,"tagName":"div"}]